NCT00001509View on ClinicalTrials.gov

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 31, 1996

Study Completion Date

May 31, 2000

Conditions

NephroblastomaNeuroblastoma

Interventions

DRUG

IFN-alpha with retinoic acid

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH